Author Index: K
• ORAL ABSTRACTS: INFECTIOUS DISEASE CONTROL
• LEVERAGING CANCER MODELS TO EXPLORE THE NATURAL HISTORY OF THE CAUSAL HUMAN PAPILLOMAVIRUS (HPV) INFECTION
• IDENTIFYING RESOURCE USE AND CAPACITY CONSTRAINT TRADEOFFS ASSOCIATED WITH IMPLEMENTING NEW SCREENING GUIDELINES IN NORWAY
• THE IMPACT OF TIME TO DIAGNOSTIC ASSESSMENT ON SCREENING EFFICACY
• RISK-BASED ADAPTIVE SCREENING FOR CERVICAL CANCER
• LEVERAGING CANCER MODELS TO EXPLORE THE NATURAL HISTORY OF THE CAUSAL HUMAN PAPILLOMAVIRUS (HPV) INFECTION
• IDENTIFYING RESOURCE USE AND CAPACITY CONSTRAINT TRADEOFFS ASSOCIATED WITH IMPLEMENTING NEW SCREENING GUIDELINES IN NORWAY
• THE IMPACT OF TIME TO DIAGNOSTIC ASSESSMENT ON SCREENING EFFICACY
• RISK-BASED ADAPTIVE SCREENING FOR CERVICAL CANCER
• INVESTIGATING STRUCTURAL INDEPENDENCE IN PREFERENCE-BASED UTILITY INSTRUMENTS USING GRAPHICAL MODELS
• VALIDATING THE BLADDER UTILITY SYMPTOM SCALE (BUSS): A MULTIATTRIBUTE HEALTH STATE CLASSIFICATION SYSTEM FOR ALL PATIENTS WITH BLADDER CANCER
• PANEL: RECOMMENDATIONS OF THE SECOND PANEL ON COST-EFFECTIVENESS IN HEALTH AND MEDICINE
• COST-EFFECTIVENESS ANALYSIS OF DRUGS FOR CHRONIC HEPATITIS C INFECTION: INFORMING ON LISTING DECISIONS OF INTERFERON-FREE DIRECT-ACTING ANTIVIRAL REGIMENS IN CANADA
• CORNEAL CROSS-LINKING VERSUS PENETRATING KERATOPLASTY IN THE TREATMENT OF KERATOCONUS: A COST-EFFECTIVENESS ANALYSIS
• PREFERENCES OF PREGNANT WOMEN AND FAMILY MEMBERS FOR COMBINED MATERNAL-FETAL HEALTH STATES ARISING FROM THE USE OF ANTICOAGULATION IN PREGNANCY
• WEIGHTING OF AHI SCORES AND SYMPTOMS IN THE DIAGNOSIS OF SLEEP APNEA BY SLEEP SPECIALISTS
• A SYSTEMATIC REVIEW AND META-ANALYSIS OF HEALTH UTILITIES IN CHRONIC HEPATITIS C PATIENTS
• HEALTH UTILITIES IN CHRONIC HEPATITIS C PATIENTS WITH LATE-STAGE LIVER DISEASE
• CHALLENGES ON THE PATH TO REIMBURSEMENT OF ONCOLOGY DRUGS: INSIGHTS FROM THE COST-EFFECTIVENESS DECISIONS OF THE PAN-CANADIAN ONCOLOGY DRUG REVIEW
• VALIDATING THE BLADDER UTILITY SYMPTOM SCALE (BUSS): A MULTIATTRIBUTE HEALTH STATE CLASSIFICATION SYSTEM FOR ALL PATIENTS WITH BLADDER CANCER
• PANEL: RECOMMENDATIONS OF THE SECOND PANEL ON COST-EFFECTIVENESS IN HEALTH AND MEDICINE
• COST-EFFECTIVENESS ANALYSIS OF DRUGS FOR CHRONIC HEPATITIS C INFECTION: INFORMING ON LISTING DECISIONS OF INTERFERON-FREE DIRECT-ACTING ANTIVIRAL REGIMENS IN CANADA
• CORNEAL CROSS-LINKING VERSUS PENETRATING KERATOPLASTY IN THE TREATMENT OF KERATOCONUS: A COST-EFFECTIVENESS ANALYSIS
• PREFERENCES OF PREGNANT WOMEN AND FAMILY MEMBERS FOR COMBINED MATERNAL-FETAL HEALTH STATES ARISING FROM THE USE OF ANTICOAGULATION IN PREGNANCY
• WEIGHTING OF AHI SCORES AND SYMPTOMS IN THE DIAGNOSIS OF SLEEP APNEA BY SLEEP SPECIALISTS
• A SYSTEMATIC REVIEW AND META-ANALYSIS OF HEALTH UTILITIES IN CHRONIC HEPATITIS C PATIENTS
• HEALTH UTILITIES IN CHRONIC HEPATITIS C PATIENTS WITH LATE-STAGE LIVER DISEASE
• CHALLENGES ON THE PATH TO REIMBURSEMENT OF ONCOLOGY DRUGS: INSIGHTS FROM THE COST-EFFECTIVENESS DECISIONS OF THE PAN-CANADIAN ONCOLOGY DRUG REVIEW
• UNDERSTANDING THE EFFECTS OF LEAD TIME AND OVERDIAGNOSIS IN MAMMOGRAPHY SCREENING: THE SCREENING ILLUSTRATOR
• USING AN INSTRUMENTAL VARIABLE TO DETERMINE THE CAUSAL EFFECT OF OPPORTUNISTIC MAMMOGRAPHY ON BREAST CANCER MORTALITY
• IDENTIFYING RESOURCE USE AND CAPACITY CONSTRAINT TRADEOFFS ASSOCIATED WITH IMPLEMENTING NEW SCREENING GUIDELINES IN NORWAY
• VALUE OF PERFECT IMPLEMENTATION: INCREASING ADHERENCE TO CHOLESTEROL LOWERING THERAPIES
• USING AN INSTRUMENTAL VARIABLE TO DETERMINE THE CAUSAL EFFECT OF OPPORTUNISTIC MAMMOGRAPHY ON BREAST CANCER MORTALITY
• IDENTIFYING RESOURCE USE AND CAPACITY CONSTRAINT TRADEOFFS ASSOCIATED WITH IMPLEMENTING NEW SCREENING GUIDELINES IN NORWAY
• VALUE OF PERFECT IMPLEMENTATION: INCREASING ADHERENCE TO CHOLESTEROL LOWERING THERAPIES
• ORAL ABSTRACTS: CANCER SCREENING AND PREVENTION
• PANEL: RECOMMENDATIONS OF THE SECOND PANEL ON COST-EFFECTIVENESS IN HEALTH AND MEDICINE
• INFORMING MEDICATION DISCONTINUATION DECISIONS AMONG ADULTS WITH MULTIPLE SCLEROSIS
• IMMEDIATE COLECTOMY VERSUS ENHANCED SURVEILLANCE FOR LOW-GRADE DYSPLASIA IN ULCERATIVE COLITIS
• BAYESIAN PREDICTION OF PREVALENCE OF HUMAN PAPILLOMAVIRUS IN YOUNG GIRLS IN THE US FROM AGGREGATED DATA USING EXPONENTIALLY DAMPED POLYNOMIAL MODELS
• PANEL: RECOMMENDATIONS OF THE SECOND PANEL ON COST-EFFECTIVENESS IN HEALTH AND MEDICINE
• INFORMING MEDICATION DISCONTINUATION DECISIONS AMONG ADULTS WITH MULTIPLE SCLEROSIS
• IMMEDIATE COLECTOMY VERSUS ENHANCED SURVEILLANCE FOR LOW-GRADE DYSPLASIA IN ULCERATIVE COLITIS
• BAYESIAN PREDICTION OF PREVALENCE OF HUMAN PAPILLOMAVIRUS IN YOUNG GIRLS IN THE US FROM AGGREGATED DATA USING EXPONENTIALLY DAMPED POLYNOMIAL MODELS
• ‘EXPERT ADVICE' FOR DEVELOPING DECISION SUPPORT: A QUALITATIVE STUDY OF WOMEN WHO HAVE EXPERIENCED PERIVIABLE BIRTH
• EDUCATION COMMITTEE MEETING
• HEALTH UTILITY ESTIMATES AMONG PERSONS LIVING WITH HIV IN THE U.S. – IMPLICATIONS FOR COST-EFFECTIVENESS MODELING AND FUTURE RESEARCH NEEDS
• EFFECT OF COUNSELING QUALITY ON PSYCHOLOGICAL OUTCOMES AFTER SECOND-TRIMESTER TERMINATION FOR PREGNANCY COMPLICATIONS
• PARENTS' PERSPECTIVES ON ANTENATAL DECISION MAKING FOR THE ANTICIPATED BIRTH OF A PERIVIABLE INFANT
• EDUCATION COMMITTEE MEETING
• HEALTH UTILITY ESTIMATES AMONG PERSONS LIVING WITH HIV IN THE U.S. – IMPLICATIONS FOR COST-EFFECTIVENESS MODELING AND FUTURE RESEARCH NEEDS
• EFFECT OF COUNSELING QUALITY ON PSYCHOLOGICAL OUTCOMES AFTER SECOND-TRIMESTER TERMINATION FOR PREGNANCY COMPLICATIONS
• PARENTS' PERSPECTIVES ON ANTENATAL DECISION MAKING FOR THE ANTICIPATED BIRTH OF A PERIVIABLE INFANT